Denali Therapeutics
This role leads a dedicated DMPK team within the Nonclinical Safety Assessment and DMPK group, providing scientific and strategic input to advance a portfolio of blood-brain-barrier penetrant biotherapeutics from Discovery through CTA/IND-enabling studies. The individual serves as both a hands-on subject-matter expert and a people leader, collaborating closely with various scientific and regulatory teams to shape PK, drug disposition, and translational pharmacology strategy. The position involves building scientific talent, representing DMPK on the Development Sciences Leadership Team, and supporting registration efforts.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
6% above the average for this role
Sr. Principal Scientist / Director, DMPK & Bioanalytical Sciences
Flagship Pioneering, Inc.
Sr. Principal Scientist / Director, DMPK & Bioanalytical Sciences
Alltrna
Scientist/Senior Scientist
ASTARPRD
Translational Scientist
bauschlomb.com
DMPK Expert
General Proximity
Senior Principal Scientist, DMPK
Cogent Biosciences